Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort

dc.contributor.authorVazirani, Ravi
dc.contributor.authorAlmendro Delia, Manuel
dc.contributor.authorBlanco Ponce, Emilia
dc.contributor.authorMartín García, Agustín C.
dc.contributor.authorFernández Cordón, Clara
dc.contributor.authorUribarri, Aitor
dc.contributor.authorAndrés, Mireia de
dc.contributor.authorMartínez Sellés Oliveria Soares, Manuel
dc.contributor.authorNúñez Gil, Iván Javier
dc.contributor.authorRETAKO Investigators
dc.contributor.authorEt al.
dc.date.accessioned2024-05-11T11:39:18Z
dc.date.available2024-05-11T11:39:18Z
dc.date.issued2024
dc.description.abstractntroduction: Data on the association between kidney function and Takotsubo syndrome (TTS) outcomes are scarce and conflictive. Objective: To assess the impact of chronic kidney disease (CKD) and acute renal failure (ARF) in patients with TTS. Material and methods: Patients from the prospective nation-wide (RETAKO) registry were included and divided into quartiles of maximum creatinine (Cr) level during hospitalization. Results: The prevalence of CKD and ARF in the whole RETAKO cohort was 5.4% and 11.7%, respectively. Compared to Q1 (Cr <0.71), patients within Q4 (Cr > 1.1) had lower left ventricular ejection fraction on admission (38.5 ± 12 vs 43.3 ± 11.3, p = 0.002) and higher bleeding rates during hospitalization (6.7% vs 2%, p = 0.005). In addition, compared to Q1, Q4 patients have a greater incidence of cardiogenic shock (17.3% vs 5.6%, p < 0.001), and a higher rate of 5-year all-cause death and major adverse cardiovascular events (31.5% vs 15.8%, p < 0.001 and 22.5% vs 9.3%, p < 0.001, respectively). Conclusions: TTS patients with CKD have a higher incidence of ARF and exhibit greater Cr on admission, which were linked with higher rates of cardiogenic shock, bleeding during hospitalization as well as major adverse cardiovascular events and all-cause death during a 5-year follow-up.spa
dc.description.filiationUEMspa
dc.description.impact3.2 Q2 JCR 2023spa
dc.description.impact1.126 Q1 SJR 2023spa
dc.description.impactNo data IDR 2023spa
dc.description.sponsorshipSociedad Española de Cardiologíaspa
dc.description.sponsorshipMayo Clinicspa
dc.identifier.citationVazirani, R., Almendro Delia, M., Blanco-Ponce, E., Martín-García, A. C., Fernández-Cordón, C., Uribarri, A., Andrés, M., Vedia, O., Sionis, A., Corbí-Pascual, M., Salamanca, J., Pérez-Castellanos, A., Carmona, J. D. M., Raposeiras-Roubín, S., Aritza-Conty, D., Lopez-País, J., Guillén-Marzo, M., Lluch-Requerey, C., Escudier, J. M., Martínez-Sellés, M., … RETAKO Investigators (2024). Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort. International journal of Cardiology, 405, 131971. https://doi.org/10.1016/j.ijcard.2024.131971spa
dc.identifier.doi10.1016/j.ijcard.2024.131971
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.urihttp://hdl.handle.net/11268/12810
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1016/j.ijcard.2024.131971spa
dc.rights.accessRightsrestricted accessspa
dc.subject.otherInsuficiencia renal crónicaspa
dc.subject.otherCardiomiopatía de Takotsubospa
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoEnfermedad cardiovascularspa
dc.subject.unescoMuertespa
dc.titleRenal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohortspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationa14a4cbe-6878-47e7-8b7b-ffdd4a82573a
relation.isAuthorOfPublicatione2ca7752-c935-4769-85e5-5eb5944e3178
relation.isAuthorOfPublication.latestForDiscoverya14a4cbe-6878-47e7-8b7b-ffdd4a82573a

Files